The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ezetimibe/ Atorvastatin Zentiva 10 mg/80 mg film-coated tablets

Zentiva k.s.PA1701/009/004

Main Information

Trade NameEzetimibe/ Atorvastatin Zentiva 10 mg/80 mg film-coated tablets
Active SubstancesEzetimibe
Atorvastatin calcium trihydrate
Dosage FormFilm-coated tablet
Licence HolderZentiva k.s.
Licence NumberPA1701/009/004

Group Information

ATC CodeC10BA05 atorvastatin and ezetimibe


License statusAuthorised
Licence Issued23/02/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back